NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

BrightGene Bio-Medical Technology Co. Ltd (SHG: 688166)

 
688166 Technical Analysis
5
As on 18th Jul 2025 688166 SHARE Price closed @ 86.29 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 30.34 & Strong Buy for SHORT-TERM with Stoploss of 28.61 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

688166SHARE Price

Open 74.50 Change Price %
High 88.00 1 Day 11.08 14.73
Low 74.50 1 Week 30.39 54.36
Close 86.29 1 Month 34.52 66.68
Volume 18489019 1 Year 55.83 183.29
52 Week High 71.01 | 52 Week Low 20.30
 
SHG China Most Active Stocks
600010 2.14 6.47%
600705 3.47 0.29%
600811 0.36 -2.70%
600111 32.96 9.87%
600050 5.45 1.30%
601288 6.22 1.47%
600157 1.40 0.72%
601360 10.96 0.83%
600751 4.10 9.92%
603300 11.78 0.94%
 
SHG China Top Gainers Stocks
688360 24.44 14.74%
688166 86.29 14.73%
600462 0.21 10.53%
600792 4.05 10.05%
601003 6.13 10.05%
600343 13.81 10.04%
603115 19.64 10.03%
603496 28.34 10.02%
600826 14.49 10.02%
600619 13.73 10.02%
 
SHG China Top Losers Stocks
600256 5.45 -10.36%
688199 22.19 -8.80%
600604 6.42 -8.29%
688388 20.42 -8.02%
603129 214.13 -7.46%
600537 3.57 -7.03%
605168 32.40 -6.87%
600804 0.14 -6.67%
600201 9.00 -5.56%
603093 25.61 -5.29%
 
 
688166
Daily Charts
688166
Intraday Charts
Whats New @
Bazaartrend
688166
Free Analysis
 
688166 Important Levels Intraday
RESISTANCE112.30
RESISTANCE103.96
RESISTANCE98.80
RESISTANCE93.65
SUPPORT78.93
SUPPORT73.78
SUPPORT68.62
SUPPORT60.28
 
688166 Forecast July 2025
4th UP Forecast114.33
3rd UP Forecast105.34
2nd UP Forecast99.78
1st UP Forecast94.22
1st DOWN Forecast78.36
2nd DOWN Forecast72.8
3rd DOWN Forecast67.24
4th DOWN Forecast58.25
 
688166 Weekly Forecast
4th UP Forecast94.38
3rd UP Forecast91.79
2nd UP Forecast90.18
1st UP Forecast88.58
1st DOWN Forecast84.00
2nd DOWN Forecast82.40
3rd DOWN Forecast80.79
4th DOWN Forecast78.20
 
688166 Forecast2025
4th UP Forecast218.04
3rd UP Forecast175.79
2nd UP Forecast149.67
1st UP Forecast123.55
1st DOWN Forecast49.03
2nd DOWN Forecast22.91
3rd DOWN Forecast-3.21
4th DOWN Forecast-45.46
 
 
688166 Other Details
Segment EQ
Market Capital 12615700480.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
688166 Address
688166
 
688166 Latest News
 
Your Comments and Response on BrightGene Bio-Medical Technology Co. Ltd
 
688166 Business Profile
BrightGene Bio-Medical Technology Co., Ltd., a biopharmaceutical company, engages in the research and development, manufacture, and commercialization of medicines, and generic APIs and FDFs in China. Its product pipeline includes immuno-oncological therapeutic agents, orally available GLP-1RA peptides for type 2 diabetes, antibody drug conjugates for solid tumor, and novel non-antibody dependent tumor targeting conjugates for brain cancer and solid tumor brain-metastasis. The company also develops Eribulin, Trabectedin, Fondaparinux, Caspofungin, and non-biological molecules; macromolecules, such as Ferumoxytol and Ferric pyrophosphate citrate; and ADC cytotoxic payloads comprising Maytansinoids, Auristatins, and Calicheamicin. It offers cardiovascular, antibacterial, ADC, oncology, antifungal, iron supplement, anti-HBV, veterinary, and immuno products. The company was founded in 2001 and is based in Suzhou, China. Address: Building C25-28, Suzhou, China, 215123
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service